Skip to main
VTR

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 64%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Ventas is a healthcare REIT with a diversified portfolio of properties, including senior housing, medical office, hospital, life science, and skilled nursing/post-acute care facilities. The company also has a strategic focus on sustainability, with goals aligned with the United Nations Sustainable Development Goals. With a large and diverse portfolio and a focus on long-term sustainability, Ventas is well-positioned for growth and has the potential to reach a stock price of $123 in the next 12 months.

Bears say

Ventas is a strong player in the healthcare REIT industry, owning a large and diversified portfolio of healthcare properties. However, due to the company's reliance on investments for growth and potential challenges in the healthcare landscape, there are concerns for the company's long-term outlook. Additionally, while Ventas has a strong focus on sustainability, its stock price could struggle if the senior housing market returns to historical growth rates and development activity ramps up.

Ventas (VTR) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 64% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 14 analysts, Ventas (VTR) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $100.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $100.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.